Related Funds
| Fund Name | Location |
| Arun | Japan, Tokyo |
| Atlantic Bridge | County Dublin, Dublin, Ireland |
| Brown Advisory | Austin, Texas, United States |
| Collins Community Credit Union | Cedar Rapids, Iowa, United States |
| Contents innovation Program | Japan, Tokyo |
| Desai Family Office. | - |
| Earth Capital | England, London, United Kingdom |
| Eurofactor (UK) | England, London, United Kingdom |
| Greenlight Capital | New York, New York, United States |
| Guoxin Zhuoyue Venture Capital | Beijing, Beijing, China |
| Ifensi.com | Beijing, Beijing, China |
| Integrity Applications | Ashkelon, HaDarom, Israel |
| Joseph Rowntree Foundation | England, United Kingdom, York |
| M5Invest Partners | Pennsylvania, United States, Villanova |
| Missouri Soybean | Jefferson City, Missouri, United States |
| Otsuka Pharmaceutical | Chiyoda, Japan |
| Q management | New York, New York, United States |
| Radar Capital | - |
| Radical Investments LP | Dallas, Texas, United States |
| Talk City | Massachusetts, North Andover, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
CG Pharmaceuticals | $12M | 25 Jun 2014 | Seongnam-si, Gyeonggi-do, South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
CG Pharmaceuticals | $12M | 25 Jun 2014 | Seongnam-si, Gyeonggi-do, South Korea |
